Literature DB >> 22219226

Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.

Marco Campos1, Ashley Buchanan, Fuli Yu, Maja Barbalic, Yang Xiao, Lloyd E Chambless, Kenneth K Wu, Aaron R Folsom, Eric Boerwinkle, Jing-fei Dong.   

Abstract

Factor VIII (FVIII) functions as a cofactor for factor IXa in the contact coagulation pathway and circulates in a protective complex with von Willebrand factor (VWF). Plasma FVIII activity is strongly influenced by environmental and genetic factors through VWF-dependent and -independent mechanisms. Single nucleotide polymorphisms (SNPs) of the coding and promoter sequence in the FVIII gene have been extensively studied for effects on FVIII synthesis, secretion, and activity, but impacts of non-disease-causing intronic SNPs remain largely unknown. We analyzed FVIII SNPs and FVIII activity in 10,434 healthy Americans of European (EA) or African (AA) descent in the Atherosclerosis Risk in Communities (ARIC) study. Among covariates, age, race, diabetes, and ABO contributed 2.2%, 3.5%, 4%, and 10.7% to FVIII intersubject variation, respectively. Four intronic FVIII SNPs associated with FVIII activity and 8 with FVIII-VWF ratio in a sex- and race-dependent manner. The FVIII haplotypes AT and GCTTTT also associated with FVIII activity. Seven VWF SNPs were associated with FVIII activity in EA subjects, but no FVIII SNPs were associated with VWF Ag. These data demonstrate that intronic SNPs could directly or indirectly influence intersubject variation of FVIII activity. Further investigation may reveal novel mechanisms of regulating FVIII expression and activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219226      PMCID: PMC3293647          DOI: 10.1182/blood-2011-10-383661

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Characterization of the human factor VIII gene.

Authors:  J Gitschier; W I Wood; T M Goralka; K L Wion; E Y Chen; D H Eaton; G A Vehar; D J Capon; R M Lawn
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

2.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

Review 3.  Elevated hemostatic factor levels as potential risk factors for thrombosis.

Authors:  Wayne L Chandler; George M Rodgers; Jason T Sprouse; Arthur R Thompson
Journal:  Arch Pathol Lab Med       Date:  2002-11       Impact factor: 5.534

4.  The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A.

Authors:  A J Vlot; E P Mauser-Bunschoten; A G Zarkova; E Haan; C L Kruitwagen; J J Sixma; H M van den Berg
Journal:  Thromb Haemost       Date:  2000-01       Impact factor: 5.249

Review 5.  Sequence variation at the human ABO locus.

Authors:  S P Yip
Journal:  Ann Hum Genet       Date:  2002-01       Impact factor: 1.670

6.  Creation of a novel donor splice site in intron 1 of the factor VIII gene leads to activation of a 191 bp cryptic exon in two haemophilia A patients.

Authors:  R D Bagnall; N H Waseem; P M Green; B Colvin; C Lee; F Giannelli
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

Review 7.  Structure and function of the factor VIII gene and protein.

Authors:  Arthur R Thompson
Journal:  Semin Thromb Hemost       Date:  2003-02       Impact factor: 4.180

8.  Expression of active human factor VIII from recombinant DNA clones.

Authors:  W I Wood; D J Capon; C C Simonsen; D L Eaton; J Gitschier; B Keyt; P H Seeburg; D H Smith; P Hollingshead; K L Wion; E Delwart; E G Tuddenham; G A Vehar; R M Lawn
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

9.  Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease.

Authors:  E G Tuddenham; R S Lane; F Rotblat; A J Johnson; T J Snape; S Middleton; P B Kernoff
Journal:  Br J Haematol       Date:  1982-10       Impact factor: 6.998

10.  Detection of factor VIII/coagulant antigen in human liver tissue.

Authors:  H V Stel; T H van der Kwast; E C Veerman
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

View more
  13 in total

1.  ABO blood group polymorphisms and risk for ischemic stroke and peripheral arterial disease.

Authors:  Adriano de Paula Sabino; Daniel Dias Ribeiro; Caroline Pereira Domingheti; Danyelle Romana Alves Rios; Luci Maria SantAna Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

2.  Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.

Authors:  B Boylan; A S Rice; C De Staercke; M E Eyster; H M Yaish; C M Knoll; C J Bean; C H Miller
Journal:  J Thromb Haemost       Date:  2015-05-09       Impact factor: 5.824

3.  The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance.

Authors:  Ahmad H Mufti; Kenichi Ogiwara; Laura L Swystun; Jeroen C J Eikenboom; Ulrich Budde; Wilma M Hopman; Christer Halldén; Jenny Goudemand; Ian R Peake; Anne C Goodeve; David Lillicrap; Daniel J Hampshire
Journal:  Blood Adv       Date:  2018-07-10

4.  High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.

Authors:  Amanda B Payne; Connie H Miller; W Craig Hooper; Cathy Lally; Harland D Austin
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

5.  Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes.

Authors:  Q Y Wang; J Song; R A Gibbs; E Boerwinkle; J F Dong; F L Yu
Journal:  J Thromb Haemost       Date:  2013-02       Impact factor: 5.824

6.  Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.

Authors:  Karl C Desch; Ayse B Ozel; David Siemieniak; Yossi Kalish; Jordan A Shavit; Courtney D Thornburg; Anjali A Sharathkumar; Caitlin P McHugh; Cathy C Laurie; Andrew Crenshaw; Daniel B Mirel; Yoonhee Kim; Cheryl D Cropp; Anne M Molloy; Peadar N Kirke; Joan E Bailey-Wilson; Alexander F Wilson; James L Mills; John M Scott; Lawrence C Brody; Jun Z Li; David Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

7.  Coagulation factor VIII: Relationship to cardiovascular disease risk and whole genome sequence and epigenome-wide analysis in African Americans.

Authors:  Laura M Raffield; Ake T Lu; Mindy D Szeto; Amarise Little; Kelsey E Grinde; Jessica Shaw; Paul L Auer; Mary Cushman; Steve Horvath; Marguerite R Irvin; Ethan M Lange; Leslie A Lange; Deborah A Nickerson; Timothy A Thornton; James G Wilson; Marsha M Wheeler; Neil A Zakai; Alex P Reiner
Journal:  J Thromb Haemost       Date:  2020-02-20       Impact factor: 5.824

8.  Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.

Authors:  Weihong Tang; Mary Cushman; David Green; Stephen S Rich; Leslie A Lange; Qiong Yang; Russell P Tracy; Geoffrey H Tofler; Saonli Basu; James G Wilson; Brendan J Keating; Lu-Chen Weng; Herman A Taylor; David R Jacobs; Joseph A Delaney; Cameron D Palmer; Taylor Young; James S Pankow; Christopher J O'Donnell; Nicholas L Smith; Alexander P Reiner; Aaron R Folsom
Journal:  Am J Hematol       Date:  2015-04-01       Impact factor: 13.265

9.  Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects.

Authors:  Jaewoo Song; Fengju Chen; Marco Campos; Doug Bolgiano; Katie Houck; Lloyd E Chambless; Kenneth K Wu; Aaron R Folsom; David Couper; Eric Boerwinkle; Jing-fei Dong
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

10.  On the versatility of von Willebrand factor.

Authors:  Antoine Rauch; Nikolett Wohner; Olivier D Christophe; Cécile V Denis; Sophie Susen; Peter J Lenting
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-07-10       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.